公开(公告)号：US20240358945A1

公开(公告)日：2024-10-31

申请号：US18560307

申请日：2022-05-11

申请人： Ectosense nv

发明人： Frederik Roger Anne MASSIE ,  Bart VAN PEE ,  Steven Elsa Louis VITS

IPC分类号： A61M16/00 ,  A61M16/06 ,  A61M16/08 ,  A61M16/10 ,  G16H50/20 ,  G16H50/30

CPC分类号： A61M16/024 ,  A61M16/0003 ,  A61M16/0066 ,  A61M16/0683 ,  A61M16/0875 ,  A61M16/1075 ,  G16H50/20 ,  G16H50/30 ,  A61M2016/0027 ,  A61M2016/0033 ,  A61M2202/0007 ,  A61M2202/0208 ,  A61M2205/103 ,  A61M2205/3303 ,  A61M2205/3327 ,  A61M2205/3334 ,  A61M2205/3351 ,  A61M2205/3365 ,  A61M2205/3553 ,  A61M2205/3561 ,  A61M2205/42 ,  A61M2205/502 ,  A61M2205/581 ,  A61M2205/583 ,  A61M2205/75 ,  A61M2210/0606 ,  A61M2210/0618 ,  A61M2230/04 ,  A61M2230/20 ,  A61M2230/42 ,  A61M2230/63

摘要： Apparatus and methods detect sleep disordering events. The apparatus may be configured to access one or more physiological signals generated by one or more sensors. The apparatus may be configured to detect, from the one or more physiological signals, seed events suggestive of sleep disordering events. The apparatus may be configured to compute features indicative of patterns within portions of the one or more physiological signals that are associated with the detected seed events. The apparatus may be configured to apply to a classifier, the computed features indicative of patterns of the seed events. The classifier may be trained to compute a degree of fit of the computed features to learned repetitive patterns of sleep disordering events. The apparatus may be configured to output an identification of sleep disordering event(s) corresponding with the seed events based on the computed degree of fit determined by the classifier.

公开(公告)号：US20240350785A1

公开(公告)日：2024-10-24

申请号：US18685568

申请日：2022-08-22

申请人： Chaim SHECHTER ,  Or BISMUT ,  Arie WAINBERG ,  Ari Josef EICHENBAUM

发明人： Chaim SHECHTER ,  Or BISMUT ,  Arie WAINBERG ,  Ari Josef EICHENBAUM

IPC分类号： A61M37/00 ,  A61M5/42 ,  A61N5/06

CPC分类号： A61M37/0015 ,  A61M5/422 ,  A61N5/0616 ,  A61M2037/0023 ,  A61M2205/3303 ,  A61M2205/3313 ,  A61M2205/3375 ,  A61M2205/3606 ,  A61M2205/6054 ,  A61N2005/0661

摘要： The subject matter discloses a detection unit (102) adapted for performing facial skin diagnose in a treated area and for providing a first measurement of skin layers thickness or for providing a second measurement of defected or infected skin tissue in a treated area; a microneedles array 1032 adapted for performing an injection process for treating said defected or infected skin tissue; in accordance with said first measurement or said second measurement; and a cooling system adapted for cooling down said treated area prior to said injection; said cooling down is for reducing pain.

公开(公告)号：US20240347189A1

公开(公告)日：2024-10-17

申请号：US18628505

申请日：2024-04-05

申请人： Abiomed, Inc.

发明人： Zhengyang Zhang ,  Govind Bhala ,  Christian Moyer

IPC分类号： G16H40/63 ,  A61M60/13 ,  A61M60/17 ,  A61M60/216 ,  A61M60/414 ,  A61M60/531 ,  A61M60/546 ,  A61M60/554 ,  G16H20/40 ,  G16H50/30

CPC分类号： G16H40/63 ,  A61M60/13 ,  A61M60/17 ,  A61M60/216 ,  A61M60/414 ,  A61M60/531 ,  A61M60/546 ,  A61M60/554 ,  G16H20/40 ,  G16H50/30 ,  A61M2205/04 ,  A61M2205/103 ,  A61M2205/3303 ,  A61M2205/3327 ,  A61M2205/3331 ,  A61M2205/502 ,  A61M2230/30

摘要： Methods and apparatus for estimating a measure of cardiac contractility based on a set of features determined from a set of signals associated with a mechanical circulatory support device are provided. The method includes determining, using computer processor, a set of features based, at least in part, on the set of signals, providing the set of features as input to a machine learning model trained to output a measure of cardiac contractility, and performing an action based, at least in part, on the measure of cardiac contractility output by the machine learning model.

公开(公告)号：US12109419B2

公开(公告)日：2024-10-08

申请号：US17033983

申请日：2020-09-28

申请人： Peter Forsell

发明人： Peter Forsell

IPC分类号： A61M60/148 ,  A61B1/018 ,  A61B17/32 ,  A61M1/04 ,  A61M1/36 ,  A61M60/191 ,  A61M60/289 ,  A61M60/468 ,  A61M60/495 ,  A61M60/50 ,  A61M60/861 ,  A61M60/873 ,  A61M60/894 ,  A61N1/362 ,  A61N1/39

CPC分类号： A61N1/3627 ,  A61B1/018 ,  A61B17/320016 ,  A61M1/04 ,  A61M1/3627 ,  A61M60/148 ,  A61M60/191 ,  A61M60/289 ,  A61M60/468 ,  A61M60/495 ,  A61M60/50 ,  A61M60/861 ,  A61M60/873 ,  A61M60/894 ,  A61M2205/32 ,  A61M2205/33 ,  A61M2205/3303 ,  A61M2205/8243 ,  A61M2230/04 ,  A61N1/3962

摘要： The present invention relates to an implantable device for improving the pump function of the heart of a human patient by applying an external force on a first position of the heart muscle following the heart's contractions. The implantable device comprising a first pump device adapted to assist the pump function of the heart. The pump device comprises a first reservoir, a second reservoir, a fluid connection adapted to fluidly connect said first reservoir with said second reservoir, such that fluid can flow between said first reservoir and said second reservoir.

公开(公告)号：US20240325720A1

公开(公告)日：2024-10-03

申请号：US18618425

申请日：2024-03-27

申请人： Boston Scientific Scimed, Inc.

发明人： Nathan Edwards ,  Corydon Carlson

IPC分类号： A61M60/546 ,  A61M60/178 ,  A61M60/216 ,  A61M60/411 ,  A61M60/531 ,  A61M60/816

CPC分类号： A61M60/546 ,  A61M60/178 ,  A61M60/216 ,  A61M60/411 ,  A61M60/531 ,  A61M60/816 ,  A61M2205/10 ,  A61M2205/18 ,  A61M2205/3303 ,  A61M2205/3327 ,  A61M2205/3331 ,  A61M2205/3365 ,  A61M2205/50 ,  A61M2210/125

摘要： A percutaneous circulatory support system includes an impeller and a motor operably coupled to the impeller. A controller is operably coupled to the motor, and the controller is configured to: drive the motor, the motor thereby rotating the impeller to cause blood to flow; determine that an operating parameter of the system deviates from a symmetric waveform; and in response to determining that the operating parameter deviates from the symmetric waveform, provide an alert of aortic valve insufficiency.

公开(公告)号：US20240325616A1

公开(公告)日：2024-10-03

申请号：US18618801

申请日：2024-03-27

申请人： Fenwal, Inc.

发明人： Thomas Gniadek

IPC分类号： A61M1/34 ,  A61K31/194 ,  A61K35/14 ,  A61M1/36

CPC分类号： A61M1/3403 ,  A61K31/194 ,  A61K35/14 ,  A61M1/3401 ,  A61M1/3496 ,  A61M1/3693 ,  A61M2205/3303 ,  A61M2205/3334

摘要： Methods and systems for performing an apheresis procedure with a reduced risk of citrate reaction occurrences are described. The volume of body water in the apheresis subject is used to predict the likelihood of a citrate reaction during infusion of a blood component to the subject and allows for establishing and maintaining an optimal flow rate of the infused blood component.

公开(公告)号：US12102829B2

公开(公告)日：2024-10-01

申请号：US16784374

申请日：2020-02-07

申请人： Peter Forsell

发明人： Peter Forsell

IPC分类号： A61N1/362 ,  A61B1/018 ,  A61B17/32 ,  A61M1/04 ,  A61M1/36 ,  A61M60/148 ,  A61M60/191 ,  A61M60/289 ,  A61M60/468 ,  A61M60/495 ,  A61M60/50 ,  A61M60/861 ,  A61M60/873 ,  A61M60/894 ,  A61N1/39

CPC分类号： A61N1/3627 ,  A61B1/018 ,  A61B17/320016 ,  A61M1/04 ,  A61M1/3627 ,  A61M60/148 ,  A61M60/191 ,  A61M60/289 ,  A61M60/468 ,  A61M60/495 ,  A61M60/50 ,  A61M60/861 ,  A61M60/873 ,  A61M60/894 ,  A61M2205/32 ,  A61M2205/33 ,  A61M2205/3303 ,  A61M2205/8243 ,  A61M2230/04 ,  A61N1/3962

摘要： An implantable device for improving the pump function of the heart of a human patient by applying an external force on the heart muscle. The device comprises at least one pump device comprising a heart contacting organ, an operating device for operating the heart contacting organ, and an implantable pressurized fluid system. The fluid system comprises a first implantable chamber adapted to hold a pressurized fluid, wherein said first chamber is adapted to hold a fluid having a high pressure and a second implantable chamber adapted to hold a pressurized fluid, wherein said second chamber is adapted to hold a fluid having a lower pressure. The movement of the heart contacting organ assists the pump function of the heart.

公开(公告)号：US12099654B1

公开(公告)日：2024-09-24

申请号：US17838441

申请日：2022-06-13

申请人： Apple Inc.

发明人： Grant H. Mulliken ,  Srinath Nizampatnam ,  Fletcher R. Rothkopf ,  Brian Pasley ,  Izzet B. Yildiz

IPC分类号： G06F3/01 ,  A61M21/02 ,  A61M21/00

CPC分类号： G06F3/015 ,  A61M21/02 ,  G06F3/012 ,  G06F3/013 ,  A61M2021/0027 ,  A61M2021/005 ,  A61M2205/056 ,  A61M2205/3303 ,  G06F2203/011

摘要： Devices, systems, and methods that provide content that distracts a user's attention away from discomfort, for example, occurring due to a prior injury or ongoing medical condition. The content is adjusted over time based on tracking the user's attentiveness towards the content. Specifically, the user's current attentive state may be tracked using physiological sensors and used to adapt content to mitigate the perception of discomfort. In some implementations, the user's stress is also assessed and used an indication of the user's current discomfort level to better track when the user's attentive state is shifting from the content to the discomfort and adjust the content accordingly.

公开(公告)号：US20240299659A1

公开(公告)日：2024-09-12

申请号：US18666702

申请日：2024-05-16

申请人： CareFusion 303, Inc.

发明人： Brendan John BURGESS ,  Edward Stephen FERNER ,  Beth A. SCHNEIDER ,  Shannon John JOHNSON ,  Daniel M. ABAL

IPC分类号： A61M5/172 ,  A61M5/14

CPC分类号： A61M5/1723 ,  A61M2005/1405 ,  A61M2205/3303 ,  A61M2205/505 ,  A61M2205/609 ,  A61M2230/04 ,  A61M2230/10 ,  A61M2230/20 ,  A61M2230/30 ,  A61M2230/42 ,  A61M2230/63

摘要： A system and method for operating an analgesia administration system is disclosed. A control device is associated with a drug delivery device and configured to receive a first user input including at least a portion of a fingerprint of a patient, together with a second user input corresponding to a request to administer medication. The portion of the fingerprint is compared with previously-stored fingerprints to determine an identity of the patient and, in response to receiving the second user input and determining that the patient is an authorized user, one or more sensors are used to obtain one or more signals indicative of a state of the patient. If the state of the patient satisfies a set of medication delivery criteria, the drug delivery device is caused to administer a predefined amount of medication to the patient.

公开(公告)号：US20240299656A1

公开(公告)日：2024-09-12

申请号：US18595830

申请日：2024-03-05

申请人： Medcaptain Medical Technology Co., Ltd.

发明人： Shengping LI ,  Ping LI ,  Longyu WU ,  Yazhou TANG

IPC分类号： A61M5/172 ,  G16H20/17 ,  G16H40/67

CPC分类号： A61M5/1723 ,  G16H20/17 ,  G16H40/67 ,  A61M2205/3303

摘要： The invention provides an infusion device, a control method and a computer-readable storage medium. A target object, such as a patient, is infused according to a set infusion parameter and a current first physiological parameter of the target object is determined. A target infusion parameter is then determined according to the target parameter when the first physiological parameter falls outside a preset range. The target object is infused according to the target infusion parameter. The target parameter includes the first physiological parameter, a weight of the target object and/or a constant infusion parameter. When the physiological parameters of the target object fall outside the preset range, the infusion device automatically adjusts the infusion parameters of the infusion device, without requiring the healthcare personnel to manually switch the operating mode of the infusion device for adjustment of the infusion parameters, thereby improving the efficiency of the infusion device.